Novo eyes hair-loss market as Ozempic maker looks to diversify

Summary

Novo Nordisk is exploring entry into the hair-loss market as part of its diversification strategy beyond its blockbuster Ozempic franchise. The announcement reflects the company's efforts to expand into adjacent therapeutic areas.